These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1044 related items for PubMed ID: 8923830

  • 21. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults.
    Bianda T, Glatz Y, Bouillon R, Froesch ER, Schmid C.
    J Clin Endocrinol Metab; 1998 Jan; 83(1):81-7. PubMed ID: 9435420
    [Abstract] [Full Text] [Related]

  • 22. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa.
    Hotta M, Fukuda I, Sato K, Hizuka N, Shibasaki T, Takano K.
    J Clin Endocrinol Metab; 2000 Jan; 85(1):200-6. PubMed ID: 10634387
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
    Murphy MG, Bach MA, Plotkin D, Bolognese J, Ng J, Krupa D, Cerchio K, Gertz BJ.
    J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dose-response relationships between energy availability and bone turnover in young exercising women.
    Ihle R, Loucks AB.
    J Bone Miner Res; 2004 Aug; 19(8):1231-40. PubMed ID: 15231009
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study.
    Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M, Kröger H.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3174-81. PubMed ID: 10487683
    [Abstract] [Full Text] [Related]

  • 30. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [Abstract] [Full Text] [Related]

  • 31. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
    Street ME, Spaggiari C, Ziveri MA, Volta C, Federico G, Baroncelli GI, Bernasconi S, Saggese G.
    Horm Res; 2006 Jun; 66(4):162-8. PubMed ID: 16804317
    [Abstract] [Full Text] [Related]

  • 32. Effect of Transdermal Estradiol and Insulin-like Growth Factor-1 on Bone Endpoints of Young Women With Anorexia Nervosa.
    Singhal V, Bose A, Slattery M, Haines MS, Goldstein MA, Gupta N, Brigham KS, Ebrahimi S, Javaras KN, Bouxsein ML, Eddy KT, Miller KK, Schoenfeld D, Klibanski A, Misra M.
    J Clin Endocrinol Metab; 2021 Jun 16; 106(7):2021-2035. PubMed ID: 33693703
    [Abstract] [Full Text] [Related]

  • 33. Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal.
    Parkinson C, Kassem M, Heickendorff L, Flyvbjerg A, Trainer PJ.
    J Clin Endocrinol Metab; 2003 Dec 16; 88(12):5650-5. PubMed ID: 14671148
    [Abstract] [Full Text] [Related]

  • 34. Effects of a growth hormone receptor antagonist on bone markers in acromegaly.
    Fairfield WP, Sesmilo G, Katznelson L, Pulaski K, Freda PU, Stavrou S, Kleinberg D, Klibanski A.
    Clin Endocrinol (Oxf); 2002 Sep 16; 57(3):385-90. PubMed ID: 12201832
    [Abstract] [Full Text] [Related]

  • 35. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF.
    J Bone Miner Res; 1994 Sep 16; 9(9):1365-70. PubMed ID: 7817819
    [Abstract] [Full Text] [Related]

  • 36. Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone in rhesus macaque monkeys.
    Sass DA, Jerome CP, Bowman AR, Bennett-Cain A, Ginn TA, LeRoith D, Epstein S.
    J Clin Endocrinol Metab; 1997 Apr 16; 82(4):1202-9. PubMed ID: 9100597
    [Abstract] [Full Text] [Related]

  • 37. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
    Crofton PM, Ahmed SF, Wade JC, Stephen R, Elmlinger MW, Ranke MB, Kelnar CJ, Wallace WH.
    J Clin Endocrinol Metab; 1998 Sep 16; 83(9):3121-9. PubMed ID: 9745414
    [Abstract] [Full Text] [Related]

  • 38. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea.
    Grinspoon S, Miller K, Coyle C, Krempin J, Armstrong C, Pitts S, Herzog D, Klibanski A.
    J Clin Endocrinol Metab; 1999 Jun 16; 84(6):2049-55. PubMed ID: 10372709
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of bone loss and its mechanisms in anorexia nervosa.
    Legroux-Gérot I, Vignau J, D'Herbomez M, Collier F, Marchandise X, Duquesnoy B, Cortet B.
    Calcif Tissue Int; 2007 Sep 16; 81(3):174-82. PubMed ID: 17668143
    [Abstract] [Full Text] [Related]

  • 40. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
    Wang C, Eyre DR, Clark R, Kleinberg D, Newman C, Iranmanesh A, Veldhuis J, Dudley RE, Berman N, Davidson T, Barstow TJ, Sinow R, Alexander G, Swerdloff RS.
    J Clin Endocrinol Metab; 1996 Oct 16; 81(10):3654-62. PubMed ID: 8855818
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.